Shanghai Ruiliyuan Biotechnology Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Shanghai Ruiliyuan Biotechnology Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors (NCT06515314) | Shanghai Ruiliyuan Biotechnology Co., Ltd. | 2024-10-17 |
Track Shanghai Ruiliyuan Biotechnology Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.